Scholarlink

Purpose <p>Dopaminergic signalling and glucose metabolism have been implicated in autism spectrum disorder (ASD), yet in vivo evidence in the human brain remains largely unexplored. This study examined subcortical dopamine D<sub>2</sub> receptor availability and glucose metabolism in ASD to assess their clinical relevance.</p> Methods <p>In this dual-tracer PET/MR case–control study, 30 autistic and 30 neurotypical adults (age-, sex-, body mass index-, and IQ-matched) underwent [<sup>11</sup>C]raclopride PET to assess dopamine D<sub>2</sub> receptor availability, [<sup>1</sup>⁸F]FDG PET to measure glucose metabolism and resting-state fMRI to evaluate functional connectivity.</p> Results <p>Autistic individuals demonstrated increased D<sub>2</sub> receptor availability in the thalamus, with additional increases in the nucleus accumbens and putamen among autistic males compared to neurotypical males. Glucose metabolism was elevated in the thalamus and globus pallidus in ASD relative to NT, and this pattern persisted within both autistic males and autistic females in sex‑stratified comparisons. Globus pallidus and thalamic glucose metabolism correlated positively with social and communication difficulties. Resting-state fMRI analyses revealed diagnosis- and sex-dependent correlations between thalamic D<sub>2</sub> receptor availability and functional connectivity.</p> Conclusions <p>This study provides in vivo evidence of elevated subcortical D<sub>2</sub>R availability and glucose metabolism in autistic adults, a pattern observed across sexes. We also show that D<sub>2</sub>R availability is tightly linked to glucose metabolism and that D<sub>2</sub>R-functional connectivity coupling is altered in ASD, both relative to neurotypical adults and between autistic males and females. These findings highlight dopaminergic mechanisms as potential biomarkers and therapeutic targets in ASD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Subcortical dopamine D2 receptor availability and glucose metabolism in autism: a dual-tracer PET/MR study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月6日

查看全文
  • Laust Vind Knudsen,
  • Manouchehr Seyedi Vafaee,
  • Ziba Ahangarani Farahani,
  • Abigail Jane Sheldrick-Michel,
  • Tanja Maria Michel

摘要

Purpose

Dopaminergic signalling and glucose metabolism have been implicated in autism spectrum disorder (ASD), yet in vivo evidence in the human brain remains largely unexplored. This study examined subcortical dopamine D2 receptor availability and glucose metabolism in ASD to assess their clinical relevance.

Methods

In this dual-tracer PET/MR case–control study, 30 autistic and 30 neurotypical adults (age-, sex-, body mass index-, and IQ-matched) underwent [11C]raclopride PET to assess dopamine D2 receptor availability, [1⁸F]FDG PET to measure glucose metabolism and resting-state fMRI to evaluate functional connectivity.

Results

Autistic individuals demonstrated increased D2 receptor availability in the thalamus, with additional increases in the nucleus accumbens and putamen among autistic males compared to neurotypical males. Glucose metabolism was elevated in the thalamus and globus pallidus in ASD relative to NT, and this pattern persisted within both autistic males and autistic females in sex‑stratified comparisons. Globus pallidus and thalamic glucose metabolism correlated positively with social and communication difficulties. Resting-state fMRI analyses revealed diagnosis- and sex-dependent correlations between thalamic D2 receptor availability and functional connectivity.

Conclusions

This study provides in vivo evidence of elevated subcortical D2R availability and glucose metabolism in autistic adults, a pattern observed across sexes. We also show that D2R availability is tightly linked to glucose metabolism and that D2R-functional connectivity coupling is altered in ASD, both relative to neurotypical adults and between autistic males and females. These findings highlight dopaminergic mechanisms as potential biomarkers and therapeutic targets in ASD.